RecruitingPhase 2NCT03314974
Rare condition
Chronic lymphoproliferative disorder of natural killer cells
8
studies recruiting now
as of 7 Sept 2026
36
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
31 Jul 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT05978141
A Registry for People With T-cell Lymphoma
RecruitingPhase 1 / Phase 2NCT04329728
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingNCT02863692
Registry of the German CLL Study Group
RecruitingPhase 2NCT06530576
Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 8 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Chronic lymphoproliferative disorder of natural killer cells study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Chronic lymphoproliferative disorder of natural killer cells
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (STAT3).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).